<DOC>
	<DOCNO>NCT00590863</DOCNO>
	<brief_summary>This study compare whether combination antidepressant medication well one antidepressant medication alone give initial treatment people chronic recurrent major depressive disorder .</brief_summary>
	<brief_title>Combining Medications Enhance Depression Outcomes</brief_title>
	<detailed_description>The overall aim Combining Medications Enhance Depression Outcomes ( CO-MED ) enhance remission rate outpatients chronic recurrent nonpsychotic major depressive disorder ( MDD ) define DSM-IV TR , treat primary psychiatric care setting . Current evidence indicate remission , goal treatment , find one-third representative depress outpatient treat 14 week initial SSRI . In addition , even respond remit , one-third relapse subsequent 12 month . Combinations antidepressant used practice second subsequent step relapse occur long term , , case , even acutely first step speed effect clinical priority . Whether combination could potentially offer high remission rate , low attrition , great longer-term benefit use initial treatment compare monotherapy remain examined . CO-MED test whether two different medication give combination first treatment step , compare one medication , enhance remission rate , increase speed remission , tolerable , provide good sustain benefit long term . Results study inform practitioner manage treatment patient chronic recurrent MDD .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Seeking treatment primary specialty care site , plan continue live area clinic duration study Meets clinical criterion nonpsychotic MDD , recurrent ( current episode least 2 month duration ) , chronic ( current episode great 2 year ) define clinical interview confirm MINI International Neuropsychiatric Interview ( MINI ) Screening 17 item HRSD score 16 great Treatment antidepressant medication combination clinically acceptable Patient without current suicidal ideation may include study long outpatient treatment clinically appropriate Pregnant breastfeeding Plans become pregnant ensue 8 month follow study entry sexually active use adequate birth control History ( lifetime ) psychotic depression , schizophrenia , bipolar ( I , II , NOS ) , schizoaffective , Axis I psychotic disorder Current psychotic symptom ( ) History ( within last 2 year study entry ) anorexia bulimia Current primary diagnosis obsessive compulsive disorder Current substance dependence require inpatient detoxification inpatient treatment Requiring immediate hospitalization psychiatric disorder Definite history intolerance allergy ( lifetime ) protocol medication History clear nonresponse adequate trial FDAapproved monotherapy current MDE recurrent , last 2 year study entry chronic History clear nonresponse adequate trial study medication use monotherapy , one protocol combination current prior MDE Currently take study medication dose Having take Prozac ( fluoxetine ) MAOI 4 week study entry Presence unstable general medical condition ( GMC ) likely require hospitalization deem terminal ( life expectancy le 6 month study entry ) Currently take medication GMCs contraindicate study medication ( e.g. , seizure disorder ) Requiring medication GMCs contraindicate study medication Epilepsy condition require anticonvulsant Lifetime history seizure include febrile withdrawal seizure Receiving receive vagus nerve stimulation ( VNS ) , electroconvulsive therapy ( ECT ) , repetitive transcranial magnetic stimulation ( rTMS ) , somatic antidepressant treatment Currently take take within 7 day study entry follow exclusionary medication : antipsychotic medication , anticonvulsant medication , mood stabilizer , central nervous system stimulant ( antidepressant medication use treatment depression purpose smoke cessation pain exclude since agent may interfere test major hypothesis study ) Uncontrolled narrow angle glaucoma Taking thyroid medication hypothyroidism may include stable medication 3 month Using agent within 7 day study entry potential augmenting agent ( e.g. , T3 absence thyroid disease , SAMe , St. John 's Wort , lithium , buspirone ) Therapy depressionspecific</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>depression , medication , antidepressant , chronic , recurrent</keyword>
</DOC>